Back to search
FDAFDA · Food and drugs·Recall number D-0326-2024

Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1

Published February 28, 2024 · Recall initiated: February 9, 2024

Summary

FDA records drug Class II recall D-0326-2024, published February 28, 2024 and initiated February 9, 2024. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 292,752 bottles; Lot: Lot number # TX5274 Exp. 09/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: potential presence of Burkholderia cepacia complex

What to do

Voluntary: Firm initiated · Letter

Get an email if FLUTICASONE PROPIONATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FLUTICASONE PROPIONATE
Manufacturer
Apotex Corp.
Distributor
Nationwide in the USA
Lot
Lot number # TX5274 Exp. 09/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1 recalled?

Yes. FDA published recall D-0326-2024 on February 28, 2024. Reported hazard: CGMP Deviations: potential presence of Burkholderia cepacia complex

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FLUTICASONE PROPIONATE.